LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
78.63
+2.15 (2.81%)
At close: Aug 11, 2026, 4:00 PM EDT
78.58
-0.05 (-0.06%)
After-hours: Aug 11, 2026, 4:00 PM EDT
LivaNova Revenue
LivaNova had revenue of $390.59M in the quarter ending June 30, 2026, with 10.80% growth. This brings the company's revenue in the last twelve months to $1.47B, up 12.39% year-over-year. In the year 2025, LivaNova had annual revenue of $1.39B with 10.74% growth.
Revenue (ttm)
$1.47B
Revenue Growth
+12.39%
P/S Ratio
2.92
Revenue / Employee
$445,915
Employees
3,300
Market Cap
4.33B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | 134.62M | 10.74% |
| Dec 31, 2024 | 1.25B | 99.89M | 8.66% |
| Dec 31, 2023 | 1.15B | 131.74M | 12.89% |
| Dec 31, 2022 | 1.02B | -13.56M | -1.31% |
| Dec 31, 2021 | 1.04B | 101.12M | 10.82% |
| Dec 31, 2020 | 934.24M | -149.93M | -13.83% |
| Dec 31, 2019 | 1.08B | -22.79M | -2.06% |
| Dec 31, 2018 | 1.11B | 94.68M | 9.35% |
| Dec 31, 2017 | 1.01B | 47.42M | 4.91% |
| Dec 31, 2016 | 964.86M | 673.30M | 230.93% |
| Apr 24, 2015 | 291.56M | 9.54M | 3.38% |
| Apr 25, 2014 | 282.01M | 27.69M | 10.89% |
| Apr 26, 2013 | 254.32M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bruker | 3.50B |
| Integer Holdings | 1.84B |
| Haemonetics | 1.35B |
| Neogen | 870.40M |
| iRhythm Holdings | 825.34M |
| TransMedics Group | 668.47M |
| UFP Technologies | 631.64M |
| Axogen | 251.17M |
LIVN News
- 6 days ago - LivaNova price target raised to $85 from $80 at Stifel - TheFly
- 6 days ago - LivaNova price target raised to $93 from $81 at Needham - TheFly
- 6 days ago - LivaNova Earnings Call Transcript: Q2 2026 - Transcripts
- 6 days ago - LivaNova Earnings release: Q2 2026 - Filings
- 6 days ago - LivaNova Slides: Q2 2026 - Filings
- 6 days ago - LivaNova Quarterly report: Q2 2026 - Filings
- 6 days ago - LivaNova raises FY26 adjusted EPS view to $4.30-$4.40 from $4.20-$4.30 - TheFly
- 6 days ago - LivaNova reports Q2 adjusted EPS $1.26, consensus $1.09 - TheFly